Palatin Technologies, Inc. Share Price Nyse
Equities
PTN
US6960773041
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
Sales 2024 * | 4.13M 325M | Sales 2025 * | 5.25M 413M | Capitalization | 32.92M 2.59B |
---|---|---|---|---|---|
Net income 2024 * | -34M -2.68B | Net income 2025 * | -30M -2.36B | EV / Sales 2024 * | 7.98 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 6.27 x |
P/E ratio 2024 * |
-0.88
x | P/E ratio 2025 * |
-1.73
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 96.63% |
Latest transcript on Palatin Technologies, Inc.
Managers | Title | Age | Since |
---|---|---|---|
Carl Spana
FOU | Founder | 61 | 20/11/86 |
Stephen Wills
DFI | Director of Finance/CFO | 67 | 31/12/96 |
John Dodd
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
John Prendergast
FOU | Founder | 70 | 20/11/86 |
Carl Spana
FOU | Founder | 61 | 20/11/86 |
Robert deVeer
BRD | Director/Board Member | 78 | 31/10/98 |
1st Jan change | Capi. | |
---|---|---|
+9.58% | 115B | |
+12.41% | 106B | |
-2.59% | 21.96B | |
-12.38% | 21.87B | |
-5.29% | 19.21B | |
-3.35% | 18.08B | |
-38.57% | 17.71B | |
+7.51% | 14.32B | |
+35.67% | 12.42B |
- Stock Market
- Equities
- PTN Stock
- PTN Stock